ClinicalTrials.govpublic full text
Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC
esophageal squamous cell carcinoma, esophageal cancer, neoadjuvant therapy, pathological complete response (pcr), immunotherapy, chemoradiotherapy, biomarkers, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 849286
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.